Optical Biopsy Offers Early Endometrial Cancer Detection
Researchers at Washington University in St. Louis have developed a noninvasive optical biopsy method using 3D optical coherence tomography to detect endometrial cancer. This new imaging technique provides high-resolution structural and radiomic data, potentially replacing painful traditional biopsies.
Why it matters
This technology could significantly improve early cancer detection rates and patient comfort by offering a faster, safer alternative to invasive diagnostic procedures.
Endometrial cancer is the most common gynecologic cancer, with more than 69,000 cases diagnosed in the U.S. in 2025 and increasing up to 3% annually. Diagnosis requires an often painful and invasive biopsy that carries a risk of false negatives. A multidisciplinary research team at Washington University in St. Louis and Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, is looking to a fast, safe and noninvasive imaging method combined with machine learning for an accurate detection and diagnosis of precancerous lesions and early cancers.
The article reports on scientific research findings in a factual, objective manner without political or social commentary.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in